Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Digestive Diseases and Sciences|March 23, 2021
Thiopurine Monotherapy Is Effective in Maintenance of Mild-Moderate Inflammatory Bowel DiseaseGrant E Barber, Steven Hendler, Monica Choe, et al.
BMC Cancer|January 25, 2008
A complex pattern of chemokine receptor expression is seen in osteosarcomaIrene von Luettichau, Stephan Segerer, Alexandra Wechselberger, et al.
Annals of Surgery|December 21, 2010
Linking transgene expression of engineered mesenchymal stem cells and angiopoietin-1-induced differentiation to target cancer angiogenesisClaudius Conrad, Yves Hüsemann, Hanno Niess, et al.
Biological Chemistry|November 24, 2004
Imaging morphological details and pathological differences of red blood cells using tapping-mode AFMA S M Kamruzzahan, Ferry Kienberger, Cordula M Stroh, et al.
Plos One|January 12, 2024
Proteomic and transcriptomic characterisation of FIA10, a novel murine leukemic cell line that metastasizes into the brainUrsula Just, Helmut Burtscher, Sylvia Jeratsch, et al.
Annals of Surgery|November 2, 2011
Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinomaHanno Niess, Qi Bao, Claudius Conrad, et al.
Cancer Reports (Hoboken, N.J.)|November 11, 2023
Individualized targeted treatment in a case of a rare TFG::ROS1 fusion positive inflammatory myofibroblastic tumor (IMT)Sebastian Sommer, Maximilian Schmutz, Tina Schaller, et al.
The Journal of Pathology. Clinical Research|March 13, 2025
Do explainable AI (XAI) methods improve the acceptance of AI in clinical practice? An evaluation of XAI methods on Gleason gradingRobin Manz, Jonas Bäcker, Samantha Cramer, et al.
Development (Cambridge, England)|October 16, 2007
Broad, ectopic expression of the sperm protein PLCZ1 induces parthenogenesis and ovarian tumours in miceNaoko Yoshida, Manami Amanai, Tomoyuki Fukui, et al.
BMC Cancer|April 17, 2015
Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II clinical trialHanno Niess, Jobst C von Einem, Michael N Thomas, et al.
Pageof 7